The feasibility of wireless capsule endoscopy in detecting small intestinal pathology in children under the age of 8 years: a multicentre European study. by Fritscher-Ravens, A. et al.
The feasibility of wireless capsule endoscopy in
detecting small intestinal pathology in children under
the age of 8 years: a multicentre European study
A Fritscher-Ravens,1 P Scherbakov,2 P Bufler,3 F Torroni,4 T Ruuska,5 H Nuutinen,6
M Thomson,7 M Tabbers,8 P Milla9
1 Homerton University Hospital,
London, UK; 2 Academy of
Medical Sciences, Moscow,
Russia; 3 Children’s Hospital,
Munich, Germany; 4 Bambino
Gesu Hospital, Rome, Italy;
5 University Hospital, Tampere,
Finland; 6 Children’s Hospital,
Helsinki, Finland; 7 Children’s
Hospital, Sheffield, UK; 8 Emma
Children’s Hospital, AMC
Amsterdam, Netherlands; 9 UCL
Institute of Child Health London,
UK
Correspondence to:
Professor A Fritscher-Ravens,
Department of Gastroenterology,
Homerton University Hospital,
Homerton Row, London E9 6SR,
UK; fri.rav@btopenworld.com
Revised 9 April 2009
Accepted 14 April 2009
Published Online First
21 July 2009
ABSTRACT
Objective: To systematically evaluate the feasibility and
methodology to carry out wireless capsule endoscopy
(WCE) in children ,8 years to define small intestinal
pathology.
Design: Prospective European multicentre study with
negative prior investigation.
Patients and interventions: 83 children aged 1.5–
7.9 years were recruited. Initially, all were offered
‘‘swallowing’’ (Group 1) for capsule introduction. If this
failed endoscopic placement (Group 2) was used and the
Roth net, Advance or custom-made introducers were
compared.
Outcome measures: Primary endpoint: to determine
pathology; secondary endpoint: comparison of capsule
introduction methods.
Results: Capsule introduction: 20 (24%) children aged
4.0–7.9 years (mean, 6.9 years; 14 male) comprising
Group 1 were older (p,0.025) than 63 (76%) aged 1.5–
7.9 years (mean, 5.25 years; 30 male) forming Group 2.
Complications: Roth net mucosal trauma in 50%; no
others occurred. The available recording apparatus was
inappropriate for those ,3 years. Indications: gastro-
intestinal bleeding: n = 30 (16 positive findings: four
ulcerative jejunitis, four polyps, two angiodysplasia, two
blue rubber blebs, two Meckel’s diverticula, one
anastomotic ulcer, one reduplication); suspected Crohn’s
disease: n = 20 (11 had Crohn’s disease); abdominal
pain: n = 12 (six positive findings: three Crohn’s disease,
two lymphonodular hyperplasia, one blue rubber bleb);
protein loss: n = 9 (four lymphangectasia); malabsorption:
n = 12 (seven positive findings: six enteropathy, one
ascaris). No abnormalities overall: 45%.
Conclusion: WCE is feasible and safe down to the age of
1.5 years. 20 children .4 years swallowed the capsule.
The Advance introducer proved superior for endoscopic
placement. The pathologies encountered showed age
specificity and, unlike in adolescents, obscure gastro-
intestinal bleeding was the commonest indication.
Investigations in small children always require
special consideration compared to adults, as
paediatric patients have limited understanding of
procedures, and a great fear of a foreign environ-
ment. In addition, some agents, such as x rays, are
potentially damaging, and devices and instruments
are often not suitable. This is particularly evident
when the small bowel requires examination. As in
adults, radiological tests are mostly insensitive and
double balloon enteroscopy is unsuitable for the
younger child.1–4
As a consequence understanding of mucosal
pathology and the ability to diagnose lesions of
the jejunum and upper ileum is limited. There is
thus a clinical need for improved methods of
examining the small bowel in the young child.
The introduction of wireless capsule endoscopy
(WCE) has made available a new, powerful, non-
invasive imaging modality. Since the United States
Food and Drug Administration (FDA) approved
the use of WCE in patients .10 years in 2001 the
technique has been shown to be a safe with no
pain and few complications.5–14 The knowledge
obtained since its introduction has provided new
insights into a variety of diseases15–32 and has
altered the management of patients with small
intestinal diseases previously investigated with
little success by a variety of endoscopic and
radiological techniques.3 9 14 15
Several case reports, some studies and reviews of
WCE in older children and adolescents have now
been published, in whom it has been shown to be a
safe and effective means of detecting small
intestinal pathology. They are also able to swallow
the capsule and carry the necessary equipment.
Systematic studies of children ,8 years are not
available but anecdotal evidence in case reports and
papers reporting 19 children show WCE to be
feasible in this age group.22–26
There is, however, a need for robust and
systematically obtained data of WCE in young
children, as to date the indications are unclear, the
most suitable method of introduction into the
small bowel, if the capsule cannot be swallowed,
not analysed and possible complications unknown.
In this paper we describe a European multicentre
study of children under the age of 8 years, system-
atically enrolled for WCE of the small bowel when
routine endoscopy and radiological tests failed to
define pathology which explained their symptoms.
A secondary goal was to compare different means
of introducing the capsule into the bowel in those
children who could not swallow it.
PATIENTS AND METHODS
Patients
Eighty-three children aged 1.5–7.9 years (37 male,
45 female) were recruited by nine paediatric
centres throughout Europe. Their age distribution
is shown in table 1.
Children with occult gastrointestinal bleeding,
suspected Crohn’s disease, abdominal pain of
unknown aetiology, protein-losing enteropathy
and malabsorptive disorders were enrolled into
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the study if a standard barium meal and follow-through to the
terminal ileum, or abdominal magnetic resonance imaging and
upper gastrointestinal (GI) endoscopy and colonoscopy to the
caecum with biopsies carried out prior to the study were
negative or excluded small intestinal obstruction.
Exclusion criteria were children with oesophageal stricture,
small bowel and colonic stenosis or untreated congenital
bleeding disorders or under 1 year of age.
Methods
A standard Pillcam (11626 mm, 3.3 g; Given Imaging,
Yoqneam, Israel) capsule was used with paediatric- and adult-
sized aerial sensor arrays, wireless receiver, data recorder and
battery with a video imaging capture time of ,8 h producing
,50 000 images. The light was produced by white-light
emitting diodes and the images by a complementary metal
oxide silicon imager containing 2566256 pixels. The digital
signal was stored on a portable recorder, which was carried on a
belt around the patient’s waist, in a custom-made rucksack as
shown in fig 1 or, in the smallest children, placed beside them
on their cots.
All patients were given clear fluids for 24 h before the study
and fasted for 12 h overnight prior to the study. Further
preparation was left to each participating centre and is
summarised in table 2.
In order to compare endoscopic methods of capsule deploy-
ment and the devices required for this, the children were
separated into two groups. Initially, all were offered ‘‘swallow-
ing’’ for capsule introduction. Group 1 consisted of children
who were willing (or could be persuaded) to swallow the
capsule; while Group 2 consisted of patients who were unable
to swallow the capsule, and required endoscopic placement of
the capsule into the duodenum. Devices used included: (1) Roth
net;33 (2) Advance introducer (US Endoscopy, Mentor, Ohio,
USA); and (3) a custom-made acorn-like device.34 The choice of
the insertion device was left to the endoscopist, but any
complications directly attributable to the endoscopic introduc-
tion and the ease or difficulty in carrying it out were noted and
the methods and devices were compared.
Two hours after introduction of the capsule the patients were
allowed to drink clear fluids and after 4 h to have a light meal.
Patients or their parents were asked to note when the capsule
was passed in the child’s stools and to recover the capsule. Any
complications encountered were noted.
The video observers were asked to assess any macroscopic
pathological lesions, the number of lesions, and to attempt to
define their approximate position in the small bowel.
Statistical analysis
The patient demography and observations were entered into a
Microsoft Excel spreadsheet by the different recruiting centres,
collated and then subjected to statistical analysis. The Student t
test and a x2 test were used for normally distributed
populations. Data are expressed as range and mean. All p
values ,0.05 were considered statistically significant.
Ethics
A unified ethical proposal was provided for the study
participants as a template for individual applications for
approval by the appropriate ethics board of each centre.
Approval for the study was obtained for each of the participat-
ing centres after additional requests from some centres’ ethical
review boards were complied with. Three ethical review boards
feared that capsule retention would occur in such young
children. One requested that preliminary x ray studies should
only be done if there was a suspicion of obstructive symptoms.
A further board requested a small number of post-mortem
investigations to prove that the capsule would traverse the ileo-
caecal valve in infants as young as 1 year of age. These
preliminary additional studies using dummy capsules were
carried out at the Ludwig–Maximilian University, Munich,
Germany, showed that a normal-sized capsule could traverse
the ileo-caecal valve in infants down to age 6 months and
through the pylorus down to 1 year and 10 kg body weight.
These results were in accordance with at least one previous
report demonstrating that there was no correlation between
body size and capsule retention.22
RESULTS
Eighty-five studies were carried out in the 83 children aged 1.5–
7.9 years (44 male). Four (4.7%) studies in three children were
incomplete. In two children battery failure at 2.5 and 3.5 h,
respectively, was noted but, in both, relevant diagnostic
information was obtained. In another child the capsule failed
to exit the stomach on two different occasions. Subsequently, it
was introduced into the duodenum endoscopically.
Table 1 Age distribution of the patients
Age (years) Number of patients
,3 6*
3–4 14
4–5 15
5–6 14
6–7 16
7–8 18
*The ages of six patients who were ,3 years were 1.5, 1.7, 1.8,
2.1, 2.5 and 2.7 years.
Figure 1 A custom-made rucksack for the batteries and recorder in
small children.
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Twenty (24%) children aged 4.0–7.9 years (mean, 6.9 years;
14 male) were able to swallow the capsule (Group 1), while 63
(76%) aged 1.5–7.9 years (mean, 5.25 years; 30 male) were
unable to swallow it (Group 2), as shown in table 3.
The children in Group 1 were significantly older than those in
Group 2 (Group 1, 4.0–7.9 years, mean 6.9 years; Group 2, 1.5–
7.9 years, mean 5.25 years; p,0.025). The youngest child to
swallow the capsule was a boy of 4 years of age. More than
twice the number of boys (n = 14) were willing to swallow the
capsule compared to girls (n = 6). In Group 2 it was possible to
introduce the capsule endoscopically into the duodenum in all
infants (n = 63) from 1.5 years of age and 10 kg weight. Unlike
patients in Group 1 there was no difference in sex distribution
(30 male) in Group 2.
Introduction of the endoscopic capsule
Of the 63 children in whom the capsule was introduced
endoscopically, the Advance introducer was used in 39, a
custom-made introducer34 in 16 and the Roth net33 in eight.
After the first 20 patients had been studied (n = 12, Advance
introducer; n = 8, Roth net) significant mucosal trauma was
noted in 50% of procedures carried out with the Roth net. The
rigid tip of the wire holding the net led to injuries of the mucosa
when intubating the oesophagus and again but less severe on
pushing the net through the pylorus. In addition it proved
cumbersome to empty the capsule from the net in the rather
confined space of the duodenum. With the Advance introducer
capsule introduction proceeded uneventfully and it proved
easier to handle. The Roth net was subsequently abandoned
and the Advance introducer used in all centres except one, in
which the custom-made device was used throughout.
Adverse events
Significant mucosal trauma occurred in the pharynx (n = 2) at
the upper oesophageal sphincter (n = 3) and the pylorus (n = 1)
in 4/8 patients in whom the Roth net was used. No further
complication was noted and specifically no capsule retention
occurred.
Clinical indications
WCE was undertaken for occult GI bleeding (n = 30), suspected
Crohn’s disease (n = 20), abdominal pain of unknown aetiology
(n = 12), protein-losing enteropathy (n = 9) and malabsorption
(n = 12) in children in whom standard investigations had failed
to yield the cause of their symptoms. Patients with obscure GI
bleeding, protein-losing enteropathy and malabsorption were
significantly younger than those suspected of having Crohn’s
disease or recurrent abdominal pain, as shown in table 4.
Crohn’s disease (8/20) was the commonest indication in
Group 1, followed by GI bleeding (6/20), whereas in Group 2,
the majority of patients were investigated for occult GI bleeding
(24/63). The remainder of the patients in both groups were
fairly evenly distributed between the remaining three indica-
tions (table 3).
Obscure gastrointestinal bleeding
WCE identified a source of bleeding in 16/30 (age 1.5–7 years,
mean 4.5 years) patients with obscure GI bleeding and/or
chronic anaemia, six of whom were blood transfusion depen-
dent. These included four children with an ulcerative jejunitis,
three of whom were non-steroidal anti-inflammatory drug
related. All of these children suffered from juvenile rheumatoid
arthritis. Four children had polyps, two with Peutz–Jegher’s
syndrome and two nonsyndromic juvenile polyposis (fig 2A),
two angiodysplasia (fig 2B), two ‘‘blue rubber bleb’’-type
haemangiomas, two Meckel’s diverticulae, one astomotic ulcer
(fig 2C) and one reduplication of the intestine. In 14/30 children
the source of bleeding could not be found by WCE. In two
patients, lesions which were not bleeding were found: one
lymphonodular hyperplasia and one patchy partial villous
atrophy. In 12 patients, no lesions were found by WCE, two
of whom were non-symptomatic at the time of the study.
Suspected Crohn’s disease
Twenty children (age 5–8 years, mean 7.35 years) were sus-
pected of suffering from small intestinal Crohn’s disease but in
whom upper and lower intestinal endoscopy failed to provide a
diagnosis. In 11/20 evidence of small intestinal Crohn’s disease
was found which varied from diffuse apthous ulcerations
(fig 2D) throughout the small bowel to deeper ulceration and
fissuring with (fig 2E) terminal ileitis. All 11 of the patients had
evidence of acute active disease. In three, additional colonic
disease was found with WCE although the screening colono-
scopy had been negative. In 9/20 children no lesions were found.
Table 2 Bowel preparations used in the participating centres
Bowel preparation Centres, n Patients % Outcome
Clear fluids only 3 40 Mucosa satisfactorily seen, but some food residues
+Senna & picolax 1 8 3 patients vomited during preparation. Mucosa partially obscured but
positive diagnoses made
+Klean Prep 5 52 Good preparation but bubbles in some. Mucosa well seen
Table 3 Method of introducing the capsule into the duodenum of children in Groups 1 and 2
Group
Age (years) Sex
Method n ComplnRange Mean Male Female
1 4.0–7.9 6.9 14 6 Swallow 20 0
2 1.5–7.5 5.25 30 33 Roth net 8 4
Advance 39 0
Custom made 16 0
Total 1.5–7.9 5.11 44 39 83 4
Difference in age range group 1 vs group 2: p(0.05.
Compln: complications.
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Abdominal pain
Six of 12 patients (age 4.5–8.0 years, mean 6.3 years) with
recurrent abdominal pain were found to have significant
pathology. Three patients had small intestinal Crohn’s disease
(fig 2D,E), which accounted for the complaints, one had a ‘‘blue
rubber bleb’’, and two had lymphonodular hyperplasia, one of
whom had juvenile rheumatoid arthritis. The other six children
had completely normal studies. In two of those a final diagnosis
of non-ulcer dyspepsia was made on further investigation.35
Protein-losing enteropathy
Nine children (2.5–7.5 years, mean 4.1 years) had protein loss
from the bowel for which no cause had been found. Despite
normal duodenal biopsies, four had lymphangectasia and two
had lymphonodular hyperplasia on WCE. The remaining three
children had no detectable abnormality of their small intestine.
Malabsorption
Of the 12 patients (3.0–7.5 years, mean 4.8 years) with
malabsorption and suspected enteropathy in six, all of whom
had normal duodenal histology at prior endoscopy, varying
degrees of villous atrophy were detected on WCE. Two of those
had subtotal and four patchy partial villous atrophy. In none of
the six patients was the final diagnosis coeliac disease. In the
remaining six children no abnormality of the small intestine
was detected. One had sucrose intolerance and two were food
allergic but in three no cause was found for their failure to
thrive at the time of this study, although in one patient there
was an infestation with Ascaris lumbricoides (fig 2F).
Technical considerations
In the older toddlers (.3 years) and children up to 8 years of
age there was enough room on the abdomen for the aerial
electrodes and although the battery pack and recorder were
heavy for the children they were able to carry them using the
normal harness. For the youngest children the aerial sensors
were trimmed to allow them to be placed on the abdomen in
the appropriate position. The normal harness with battery pack
and recorder was far too big and heavy for them. For these
infants and toddlers the harness batteries and recorder were
simply placed in the cot or ‘‘buggy’’ beside them or carried in a
rucksack containing the battery pack and recorder (fig 1).
DISCUSSION
WCE is an endoscopic technique that offers an extremely safe
approach to the investigation of small bowel pathology in
adults and is potentially applicable in children where the
alternatives are invasive, uncomfortable or require ionising
radiation.2 36 To our knowledge only few capsule examinations
in children of ,8 years have been reported in the literature.22–26
The inability to swallow the capsule, a fear of capsule retention
and a lack of FDA approval in this age group in the US,
accompanied by the smaller number of patients requiring
evaluation of the small bowel, have severely restricted
systematic evaluation. The paucity of previous studies resulted
in this multicentre approach in order to recruit sufficient
children to systematically evaluate WCE in small children.
A major concern of both investigators and ethical review
boards was the fear of capsule retention, which has been shown
to be the most frequent complication of 1–2%.5 7 As a
consequence preliminary post-mortem studies were performed
in one centre, which successfully proved the ability of the
capsule to traverse the pylorus and ileo-caecal valve in infants of
1 year of age. There were no instances of capsule retention in
the 85 examinations of our group with the smallest child
weighing just 10 kg. This might occur, however, if a larger
group of infants was examined even if care was taken to exclude
obstructive conditions. But it seems that there is no higher
incidence to be feared when compared to adults.5 7
Failure of the capsule to exit the stomach may be experienced
in the presence of accompanying diseases including neurological
or motility disorders, which was seen in our study. As a
consequence it might be worthwhile to use endoscopic insertion
as the first choice rather than swallowing in these children. If
drugs such as opiates, which influence peristalsis, are used as
well37 the effects may be similar.
Table 4 Indications and findings of positive capsule studies and their distribution among the groups overall
Age range,
years (mean) Patients, n
Positive
studies, n Findings n
No
pathology, n
Gastrointestinal
bleeding
1.5–7.0 (4.5) 30 16 Ulcerative jejunitis 4 14
Polyposis 4
Angiodysplasia 2
Blue rubber bleb 2
Meckel’s diverticulum 2
Anastomotic ulcer 1
Reduplication 1
Crohn’s disease 5.0–7.9 (7.35) 20 11 Small intestinal Crohn’s disease 8 9
Crohn’s colitis 3
Abdominal pain 4.5–7.9 (6.3) 12 6 Small intestinal Crohn’s disease 3 6
Lymphonodular hyperplasia 2
Blue rubber bleb 1
Protein loss 1.5–7.5 (4.1) 9 6 Lymphangectasia 4 3
Lymphonodular hyperplasia 2
Malabsorption 3.0–7.5 (4.8) 12 6 Non-coeliac 6
Enteropathy 6
Ascaris 1
Difference in age range: gastrointestinal bleeding vs Crohn’s disease, p(0.01; gastrointestinal bleeding vs abdominal pain,
p(0.05; protein-losing enteropathy vs Crohn’s disease, p(0.01; protein-losing enteropathy vs abdominal pain, p(0.05;
malabsorption vs Crohn’s disease, p(0.01; and malabsorption vs abdominal pain, p(0.05.
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In a previous review it was stated that children under the age
of 9 years37 would be unable to swallow the capsule due to its
large size. In this study 24% of the recruited children swallowed
it without undue difficulty, the youngest being just 4 years of
age. Various factors accounted for the fact that a child could or
would swallow the device. These included the child’s person-
ality, acceptance by the parent(s) that the capsule could be
swallowed and the skill of the investigator in challenging the
child’s ability. In this study boys were significantly more likely
to swallow it than girls (14 boys vs 6 girls; p = 0.025). The
ability of the investigator to turn the investigation into an
interactive game was a major factor, which proved more helpful
than previous suggestions of training with candies.17
However, endoscopic introduction into the duodenum was
necessary in the majority of children (76%). The use of the Roth
net resulted in mucosal trauma in 50% of the patients and was
cumbersome to use even if an end-cap33 was added. It was thus
abandoned, especially when the purpose-made Advance intro-
ducer proved to be easier to handle and non-traumatic. But the
loaded capsule increases the overall diameter and it was
previously thought to be unsuitable for use in infants.22 These
concerns proved unjustified in our study.
To the best of our knowledge, there have been no studies of
bowel preparation in young children and its necessity is
controversial.11 37 We left the mode of preparation to the single
centres, as each of them reported good experience with ‘‘their’’
certain method. Although we did not carry out a formal study
the results seen after using three different methods amongst the
participating centres as described in table 2 show that clear
fluids 24 h prior to WCE and Klean Prep as used for colonoscopy
was the most successful regimen and this would be our
recommendation.
Since its introduction WCE has provided clinically useful
information in the management of a wide variety of well-
known different bowel disorders, as shown in table
53–6 10 12 16 18 22 which shows that it is used most commonly for
differing indications at different ages.
For example, in adult practice the third commonest indication
is for coeliac disease despite the sensitivity of WCE being far
from 100% for more subtle grades of villous atrophy.29 In
childhood there are many different causes of enteropathy often
with patchy mild changes for which the sensitivity of WCE is
low. Consequently, malabsorption as an indication for WCE
should be the last resort.
Figure 2 Small intestinal lesions
causing obscure gastrointestinal bleeding.
(a) Juvenile polyp, (b) angiodysplasia,
and (c) anastomotic ulcer. (d) Apthous
ulceration and (e) ulceration and fissures
in small intestinal Crohn’s disease.
(f) Malabsorption due to an Ascaris
lumbricoides infestation.
Table 5 Indication for wireless capsule endoscopy in different age groups
Adults Children, 10–18 years Children, 1–8 years
Indication % Indication % Indication %
Obscure gastrointestinal bleeding 48 Suspected Crohn’s disease 45 Obscure gastrointestinal
bleeding
37
Suspected Crohn’s disease 25 Obscure gastrointestinal
bleeding
23 Suspected Crohn’s disease 24
Coeliac disease 20 Polyposis 22 Abdominal pain 14
Polyposis 2 Protein loss 3 Malabsorption 14
Protein loss 2 Malabsorption 3 Protein loss 10
Abdominal pain 2 Polyposis 3
Information concerning adults is taken from Mazzarolo and Brady,3 Gay and Delvaux,4 Waterman and Eliakim5 and Delvaux and Gay.6
Information regarding children of 10–18 years is taken from Sant’Anna et al,10 Antao et al,12 Arguilles-Arias et al,16 Thomson et al18
and Moy and Levine.22
Information regarding children of 1–8 years is from the present study.
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More recently, new roles have been suggested including the
diagnosis of small intestinal neoplasms,31 the evolution of
inflammatory bowel disease21 and in graft versus host disease.32
To date the few studies that have been carried out in children
.10 years show that WCE has particularly a role in the
diagnosis of small intestinal Crohn’s disease, obscure GI
bleeding, and polyposis syndromes.2 10 12 14 16–26 Our data in
younger children suggest that obscure GI bleeding is the
commonest indication as in adults (see table 4), being 35% of
those studied. This is at variance with older children, in whom
it accounted for only 13–24%10 12 16 18 22 overall. Another marked
difference is represented by the underlying aetiology of the
haemorrhage. In our study 6/16 of the bleeding lesions were
associated with congenital and genetically determined disorders
including Meckel’s diverticulae, reduplication cysts, and Peutz–
Jegher syndrome, whilst in older children and adults this was
not the case.
Suspicion of Crohn’s disease was the second most frequent
indication, accounting for 24% in our study. In three of these
cases evidence of additional Crohn’s disease in the colon was
found on WCE despite previous negative colonoscopy, which
makes falsely negative endoscopy an important cause of
undetected disease. In contrast, in studies of older children,
Crohn’s disease accounted for 40–66%.10 12 16 18 22 The difference
in indication is due to the age of peak presentation.38 Overall,
the indications for WCE in this study of small children were
similar to older children and adults, but they were differently
distributed. The underlying diseases especially those causing GI
bleeding were also different and congenital or genetically
determined conditions were frequently present.
Furthermore, in the case of bleeding, protein loss, and
malabsorption with no other abnormal findings it is clear that
WCE might be helpful. However, our data also shows that 25%
of those who were investigated for recurrent abdominal pain
were suffering from Crohn’s disease. As at least one study has
shown that WCE has a higher sensitivity for small bowel
pathology than either radiology or endoscopy18 then we would
suggest that WCE should be carried out after upper GI
endoscopy has excluded oesophageal and gastric pathology.
Our study demonstrates that WCE is just as useful and equally
as safe in small children as in older children or adults. Much
younger children than expected were able to swallow the device
when challenged in a child-acceptable fashion. In the very small
children endoscopic introduction was necessary which proved
safe and reliable if an adequate device was used. Our study,
performed in nine centres across Europe, showed that, although in
individual centres there were differences in handling, the above
statements are valid in a wide variety of health settings.
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